About GemBio

Your trusted partner for high-purity, scalable oligonucleotide manufacturing - from concept to clinic

Current manufacturing processes are unsustainable for future demand:

Processes can’t scale for demand - Creating a commercial ceiling
>4300 kg of waste per kg of RNA - Limits capacity & sustainability
Manufacturing costs remain high - Limits affordability & adoption
Purity is variable for modified RNA - Performance & translation risk

GemBio’s manufacturing platform is built for scalability, delivering greater production capacity than conventional methods to enable more doses per year and reduce manufacturing bottlenecks.

Powered by our proprietary ClarityCapture™ technology, the platform introduces a cleavable purification tag that enables resin-free isolation of the target oligonucleotide. Paired with our optimized synthesis method, it delivers high-purity oligonucleotides and consistent CMC profiles at every scale.

We partner closely with therapeutic developers to reduce clinical translation risks and accelerate their path to the clinic.